Skip to main content
UK clinical trials - updated daily from ClinicalTrials.gov
TrialConnect
← Back to Search
Looking for participantsNA

Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy

Sponsor: University of Aberdeen

NCT ID: NCT04513054

View on ClinicalTrials.gov ↗

At a glance

What the study gets you
Access to the study treatment being tested
Type of study
Interventional (receives a drug or procedure)
Time in hospital
In-person visits at study sites — visit count not specified by the sponsor
Drug or intervention
Blood collection for genetic analysis (genetic)
How long the study runs
Study runs about 117 months (dates as stated)
About the drug or intervention
Blood collection for genetic analysis — genetic: Blood collection for genetic analysis
Patient visit burden
Not specified by the sponsor
Type of study
Testing a treatment
Ages
Not specified
Who
All
Number of participants
700
Started
2019-03-12
Last checked
2026-04

Plain English Summary

What is this study?

  • • Testing a new treatment for takotsubo cardiomyopathy
  • • NA - 700 participants
  • • Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences

Who can take part?

  • • Adults
  • • Diagnosed with takotsubo cardiomyopathy

Where?

  • • Aberdeen - Cardiac Research Office, Aberdeen Royal Infirmary
  • • Aberdeen - Cardiovascular Research Facility

This is a simplified summary. Always discuss with your doctor before making any decisions.

About This Trial

Acute stress-induced (takotsubo) cardiomyopathy or broken heart syndrome presents like a heart attack, classically is triggered by intense emotional or physical stress and can have serious health consequences. In the current study the investigators wish to establish whether there is a genetic predisposition making certain people more susceptible to this condition. This could also have implications for their families.

More detail

Acute stress-induced (takotsubo) cardiomyopathy presents like a myocardial infarct, is triggered by intense emotional or physical stress, and can have catastrophic and potentially fatal consequences. Despite data linking takotsubo cardiomyopathy with conditions that have a recognized genetic predisposition (such as mental health and neurological problems), a systematic and comprehensive characterisation of the genetic-epidemiologic factors in takotsubo is lacking. The researchers propose to further investigate this disorder by collecting blood from probands and characterising the genotype of patients with takotsubo cardiomyopathy in a large scale, nationwide genome wide association study. The investigators will also archive DNA for identification of future candidate genetic variants. Ultimately, understanding the underlying predisposition of this poorly understood neuro-psycho-cardiac disorder is essential if we are to move this field forward.

Takotsubo Cardiomyopathy

How this trial compares with your answers

Answer 2 more questions to improve match

What we know so far

Condition· Matched your search
Age· Tell us your age for better matching
Gender· Tell us your sex for better matching

Still need:

  • • Tell us your age for better matching
  • • Tell us your sex for better matching

Preliminary match based on your answers. Full eligibility requires on-site assessment including medical history, physical exam, and lab tests. This does not guarantee enrolment.

Eligibility at a Glance

Key info

  • Age: Not specified
  • Who can join: All genders

What the study is looking for

  • ✓All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date.
  • ✓Familial cases elsewhere in the world who would be willing to participate.

Who cannot take part

  • ✗Unwillingness to participate
See the full criteria
Inclusion Criteria: * All patients who have been diagnosed with Takotsubo cardiomyopathy in Scotland between 2010 to date. * Familial cases elsewhere in the world who would be willing to participate. Exclusion Criteria: * Unwillingness to participate

Where Is This Study? (2 UK sites)

Cardiac Research Office, Aberdeen Royal Infirmary

Aberdeen AB25 2ZD, United Kingdom

Recruiting
Site contact (verified)

Cardiovascular Research Facility

Aberdeen AB25 2ZD, United Kingdom

Recruiting
Site contact (verified)

How to Get in Touch

Amelia E Rudd, MSc

Sponsor contact

CONTACT

01224559473 a.e.rudd@abdn.ac.uk
Data sourced from ClinicalTrials.gov · Last verified: 2026-04